115 related articles for article (PubMed ID: 3495005)
1. Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.
Martin DE; Zalman LS; Jung G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 May; 84(9):2946-50. PubMed ID: 3495005
[TBL] [Abstract][Full Text] [Related]
2. The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells.
Zalman LS; Martin DE; Jung G; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2426-9. PubMed ID: 3494251
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.
Müller-Eberhard HJ
Immunol Rev; 1988 Mar; 103():87-98. PubMed ID: 3292398
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.
Zalman LS; Brothers MA; Chiu FJ; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5262-6. PubMed ID: 3460090
[TBL] [Abstract][Full Text] [Related]
5. Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytes.
Martin DE; Zalman LS; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):213-7. PubMed ID: 2963326
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
Jung G; Martin DE; Müller-Eberhard HJ
J Immunol; 1987 Jul; 139(2):639-44. PubMed ID: 3110277
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
8. Requirement of monocytes and T-helper cells during development of tumor cell cytotoxicity in targeted T cells.
Smans KA; Hoylaerts MF; De Broe ME
Cancer Immunol Immunother; 1994 Jan; 38(1):43-52. PubMed ID: 8299118
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.
Jung G; Ledbetter JA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4611-5. PubMed ID: 3110771
[TBL] [Abstract][Full Text] [Related]
10. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
Platsoucas CD; Good RA
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
[TBL] [Abstract][Full Text] [Related]
13. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
Tatake RJ; Guha A; Mukherji B
Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
Ceuppens JL; Baroja ML
J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
[TBL] [Abstract][Full Text] [Related]
15. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
Zhu HG; Klein-Franke A; Anderer FA
Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
17. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
[TBL] [Abstract][Full Text] [Related]
19. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
Geppert TD; Lipsky PE
J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
[TBL] [Abstract][Full Text] [Related]
20. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
Schwarz RE; Hiserodt JC
J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
